Nan is a member of the Life Sciences Health Industry Group, practicing in the area of health care regulatory law. Her practice focuses on the intersection of health care and technology, relying on her significant expertise in Medicare and Medicaid reimbursement, HIPAA, health information privacy, and interoperability, Anti-Kickback Statute, beneficiary inducement, Stark, and 60 Day Overpayment Rule compliance to inform digital health strategies and arrangements. She has extensive experience counselling a range of health care providers and manufacturing entities (including IDTFs, telehealth providers, medical device companies, pharmacies, hospitals, and other related companies in the life sciences and health care space, along with technology companies on collaboration agreements, value-based arrangements, strategic data partnerships, mobile health solutions and applications, connected devices, and breach incident response.
- University of Maryland School of Law, 2011, 法学博士, Order of the Coif; Maryland Law Review - Executive Symposium/Articles Editor; Health Law Certificate Recipient
- Wake Forest University, 2008, 学士, Chemistry, magna cum laude, Phi Beta Kappa
- American Health Lawyers Association